Details for Patent: 11,529,333
✉ Email this page to a colleague
Which drugs does patent 11,529,333 protect, and when does it expire?
Patent 11,529,333 protects ZONISADE and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 11,529,333
Title: | Oral pharmaceutical composition comprising zonisamide and process of preparation thereof |
Abstract: | The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide. |
Inventor(s): | Swati NAGAR, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal |
Assignee: | Azurity Pharmaceuticals Inc |
Application Number: | US16/354,764 |
Patent Claim Types: see list of patent claims | More… ↓ |
Drugs Protected by US Patent 11,529,333
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | ZONISADE | zonisamide | SUSPENSION;ORAL | 214273-001 | Jul 15, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,529,333
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 3668508 | ⤷ Subscribe | |||
World Intellectual Property Organization (WIPO) | 2019038584 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |